SUBSCRIBE
SUBSCRIBE
News   Deals

Nuvilex Enters Discussions to Acquire Next Generation Technology to Treat Multiple Types of Cancer

June 14, 2011 | 
1 min read
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.
Mergers & acquisitions
MORE ON THIS TOPIC
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac
Business partners run with big arrow in different directions. Conflict, choice right way business development. Team leadership competition. Quarrel, battle and problems. Flat vector illustration
Mergers & acquisitions
Avidity Played Hardball To Land Favorable Terms in $12B Novartis Deal
November 25, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand turns dice and changes the expression 'know the rules'. to 'follow the rules'.
Drug Development
CRO Boom in APAC Region, With China at the Forefront
November 19, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
November 19, 2025
 · 
3 min read
 · 
Tristan Manalac